Biogen Inc. financial data

Symbol
BIIB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
225 Binney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
BIOGEN IDEC INC. (to 3/20/2015), BIOGEN IDEC INC (to 4/25/2007), IDEC PHARMACEUTICALS CORP / DE (to 11/12/2003), IDEC PHARMACEUTICALS CORP / CA (to 2/14/1997)
Latest financial report
10-K - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 163 % -32.8%
Quick Ratio 57.6 % +3.88%
Debt-to-equity 82.1 % -17.1%
Return On Equity 10.2 % +26%
Return On Assets 5.95 % +34.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146M shares +0.7%
Common Stock, Shares, Outstanding 146M shares +0.62%
Entity Public Float 33.7B USD -18.2%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 146M shares +0.62%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +0.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.68B USD -1.62%
Costs and Expenses 7.77B USD -9.01%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 451M USD
Income Tax Expense (Benefit) 274M USD +102%
Net Income (Loss) Attributable to Parent 1.63B USD +40.6%
Earnings Per Share, Basic 11.2 USD/shares +39.8%
Earnings Per Share, Diluted 11.2 USD/shares +40.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.4B USD -15.6%
Inventory, Net 2.46B USD -2.65%
Other Assets, Current 753M USD -36.3%
Assets, Current 7.46B USD +8.71%
Deferred Income Tax Assets, Net 324M USD -65.1%
Property, Plant and Equipment, Net 3.18B USD -3.88%
Operating Lease, Right-of-Use Asset 356M USD -15.1%
Intangible Assets, Net (Excluding Goodwill) 9.69B USD +15.9%
Goodwill 6.48B USD +4.18%
Other Assets, Noncurrent 561M USD -24.8%
Assets 28B USD +4.49%
Accounts Payable, Current 424M USD +5.18%
Employee-related Liabilities, Current 289M USD +4.34%
Liabilities, Current 5.53B USD +61%
Accrued Income Taxes, Noncurrent 157M USD -61.1%
Deferred Income Tax Liabilities, Net 191M USD -70.3%
Operating Lease, Liability, Noncurrent 335M USD -16.4%
Other Liabilities, Noncurrent 732M USD -6.25%
Liabilities 11.3B USD -5.91%
Accumulated Other Comprehensive Income (Loss), Net of Tax -136M USD +11.4%
Retained Earnings (Accumulated Deficit) 19.3B USD +9.26%
Stockholders' Equity Attributable to Parent 14.8B USD +10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 16.7B USD +13%
Liabilities and Equity 28B USD +4.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 553M USD +21.5%
Net Cash Provided by (Used in) Financing Activities -440M USD -913%
Net Cash Provided by (Used in) Investing Activities -66M USD +93.1%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 170M shares +0.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.38B USD +126%
Deferred Tax Assets, Valuation Allowance 1.01B USD -20.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 421M USD -14.2%
Depreciation 287M USD +12.8%
Payments to Acquire Property, Plant, and Equipment 45.9M USD -31.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.65B USD +40.7%
Lessee, Operating Lease, Liability, to be Paid 505M USD -14.7%
Property, Plant and Equipment, Gross 5.85B USD +2.45%
Operating Lease, Liability, Current 86.4M USD -4.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88.5M USD -7.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 103M USD -2.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 39.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 83.8M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 88.3M USD +5.75%
Deferred Tax Assets, Operating Loss Carryforwards 1.36B USD -20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8M shares 0%
Unrecognized Tax Benefits 186M USD +7.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 50.2M USD -41.7%
Additional Paid in Capital 569M USD +88.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 148M USD +31.3%
Deferred Tax Assets, Net of Valuation Allowance 2.93B USD +0.02%
Share-based Payment Arrangement, Expense -302M USD -9.88%
Interest Expense 250M USD +1.38%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%